InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Immunome Inc.

IMNM Clue Score30
United States Fiscal year ends December CIK 0001472012 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Isaac Barchas
12 Aug 2026
Director
Sold on a plan
11,048
$27.25
$301.06K
Isaac Barchas
11 Aug 2026
Director
Sold on a plan indirect
62,291
$26.23
$1.63M
Isaac Barchas
10 Aug 2026
Director
Sold on a plan indirect
10,125
$26.07
$263.96K
Isaac Barchas
7 Aug 2026
Director
Sold on a plan indirect
15,248
$26.06
$397.36K
Isaac Barchas
6 Aug 2026
Director
Sold on a plan indirect
20,840
$26.06
$543.09K
Isaac Barchas
7 Jul 2026
Director
Sold on a plan indirect
16,906
$24.20
$409.13K
Isaac Barchas
6 Jul 2026
Director
Sold on a plan indirect
83,094
$24.11
$2.00M
Isaac Barchas
2 Jul 2026
Director
Sold on a plan indirect
24,335
$23.33
$567.74K
Isaac Barchas
2 Jul 2026
Director
Sold on a plan indirect
75,665
$22.35
$1.69M
Isaac Barchas
30 Jun 2026
Director
Sold on a plan indirect
101,050
$21.12
$2.13M
Jack Higgins
2 Apr 2026
Chief Scientific Officer
Sold on a plan
9,438
$21.64
$204.24K
Isaac Barchas
22 Dec 2025
Director
Sold on a plan indirect
11,251
$22.34
$251.35K
Isaac Barchas
22 Dec 2025
Director
Sold on a plan indirect
371,949
$21.72
$8.08M
Show all 75 transactions →

What was left out

Form 4 filings counted 156
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 13
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 3,059,462
History held since 5 Oct 2020